The RabGAP TBC1D1 plays a central role in exercise-regulated glucose metabolism in skeletal muscle

Diabetes

Volumn 64, Issue 6, 2015, Pages 1914-1922

  Stöckli, Jacqueline ^a,b,c   Meoli, Christopher C ^a,b   Hoffman, Nolan J ^a,b   Fazakerley, Daniel J ^a,b   Pant, Himani ^b   Cleasby, Mark E ^d   Ma, Xiuquan ^b   Kleinert, Maximilian ^b,e   Brandon, Amanda E ^b   Lopez, Jamie A ^b   Cooney, Gregory J ^b,c   James, David E ^a,b,f  

^a UNIVERSITY OF SYDNEY   (Australia)

^b GARVAN INSTITUTE OF MEDICAL RESEARCH   (Australia)

^c UNIVERSITY OF NEW SOUTH WALES   (Australia)

^d ROYAL VETERINARY COLLEGE   (United Kingdom)

^e UNIVERSITY OF COPENHAGEN   (Denmark)

^f UNIVERSITY OF SYDNEY   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

DEOXYGLUCOSE; GLUCOSE; GLUCOSE TRANSPORTER 4; GLYCOGEN; INSULIN; RAB GUANOSINE TRIPHOSPHATASES ACTIVATING PROTEIN TBC1D1; RAB PROTEIN; UNCLASSIFIED DRUG; GUANOSINE TRIPHOSPHATASE ACTIVATING PROTEIN; NUCLEAR PROTEIN; TBC1D1 PROTEIN, MOUSE;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; EXERCISE; FAST MUSCLE; GENE OVEREXPRESSION; GLUCOSE METABOLISM; GLUCOSE TRANSPORT; IN VIVO STUDY; INSULIN TOLERANCE TEST; MALE; MEASUREMENT; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; SKELETAL MUSCLE; SLOW MUSCLE; ANIMAL; ELECTROPORATION; GENETICS; KNOCKOUT MOUSE; METABOLISM; PHYSIOLOGY; POLYACRYLAMIDE GEL ELECTROPHORESIS; REAL TIME POLYMERASE CHAIN REACTION;

ANIMALS; BODY WEIGHT; ELECTROPHORESIS, POLYACRYLAMIDE GEL; ELECTROPORATION; GLUCOSE TRANSPORTER TYPE 4; GLYCOGEN; GTPASE-ACTIVATING PROTEINS; INSULIN; MALE; MICE; MICE, KNOCKOUT; MUSCLE, SKELETAL; NUCLEAR PROTEINS; PHYSICAL CONDITIONING, ANIMAL; REAL-TIME POLYMERASE CHAIN REACTION;

EID: 84981543785     PISSN: 00121797     EISSN: 1939327X     Source Type: Journal    
DOI: 10.2337/db13-1489     Document Type: Article

References (46)

1. Stöckli J, Fazakerley DJ, James DE. GLUT4 exocytosis. J Cell Sci 2011;124: 4147-4159.
2. Richter EA, Hargreaves M. Exercise, GLUT4, and skeletal muscle glucose uptake. Physiol Rev 2013;93:993-1017.
3. Sano H, Kane S, Sano E, et al. Insulin-stimulated phosphorylation of a Rab GTPase- Activating protein regulates GLUT4 translocation. J Biol Chem 2003;278: 14599-14602.
4. Hutagalung AH, Novick PJ. Role of Rab GTPases in membrane traffic and cell physiology. Physiol Rev 2011;91:119-149.
5. Larance M, Ramm G, Stöckli J, et al. Characterization of the role of the Rab GTPase- Activating protein AS160 in insulin-regulated GLUT4 trafficking. J Biol Chem 2005;280:37803-37813.
6. Martin S, Rice JE, Gould GW, Keller SR, Slot JW, James DE. The glucose transporter GLUT4 and the aminopeptidase vp165 colocalise in tubulo-vesicular elements in adipocytes and cardiomyocytes. J Cell Sci 1997;110:2281-2291.
7. Peck GR, Ye S, Pham V, et al. Interaction of the Akt substrate, AS160, with the glucose transporter 4 vesicle marker protein, insulin-regulated aminopeptidase. Mol Endocrinol 2006;20:2576-2583.
8. Mîinea CP, Sano H, Kane S, et al. AS160, the Akt substrate regulating GLUT4 translocation, has a functional Rab GTPase- Activating protein domain. Biochem J 2005;391:87-93.
9. Sano H, Eguez L, Teruel MN, et al. Rab10, a target of the AS160 Rab GAP, is required for insulin-stimulated translocation of GLUT4 to the adipocyte plasma membrane. Cell Metab 2007;5:293-303.
10. Ramm G, Larance M, Guilhaus M, James DE. A role for 14-3-3 in insulinstimulated GLUT4 translocation through its interaction with the RabGAP AS160. J Biol Chem 2006;281:29174-29180.
11. Eguez L, Lee A, Chavez JA, et al. Full intracellular retention of GLUT4 requires AS160 Rab GTPase activating protein. Cell Metab 2005;2:263-272.
12. Brewer PD, Romenskaia I, Kanow MA, Mastick CC. Loss of AS160 Akt substrate causes Glut4 protein to accumulate in compartments that are primed for fusion in basal adipocytes. J Biol Chem 2011;286:26287-26297.
13. Roach WG, Chavez JA, Mîinea CP, Lienhard GE. Substrate specificity and effect on GLUT4 translocation of the Rab GTPase- Activating protein Tbc1d1. Biochem J 2007;403:353-358.
14. Taylor EB, An D, Kramer HF, et al. Discovery of TBC1D1 as an insulin-, AICAR-, and contraction-stimulated signaling nexus in mouse skeletal muscle. J Biol Chem 2008;283:9787-9796.
15. An D, Toyoda T, Taylor EB, et al. TBC1D1 regulates insulin- And contractioninduced glucose transport in mouse skeletal muscle. Diabetes 2010;59:1358- 1365.
16. Frøsig C, Pehmøller C, Birk JB, Richter EA, Wojtaszewski JF. Exerciseinduced TBC1D1 Ser237 phosphorylation and 14-3-3 protein binding capacity in human skeletal muscle. J Physiol 2010;588:4539-4548.
17. Jessen N, An D, Lihn AS, et al. Exercise increases TBC1D1 phosphorylation in human skeletal muscle. Am J Physiol Endocrinol Metab 2011;301:E164-E171.
18. Tan SX, Ng Y, Burchfield JG, et al. The Rab GTPase- Activating protein TBC1D4/AS160 contains an atypical phosphotyrosine-binding domain that interacts with plasma membrane phospholipids to facilitate GLUT4 trafficking in adipocytes. Mol Cell Biol 2012;32:4946-4959.
19. Chen S, Murphy J, Toth R, Campbell DG, Morrice NA, Mackintosh C. Complementary regulation of TBC1D1 and AS160 by growth factors, insulin and AMPK activators. Biochem J 2008;409:449-459.
20. Stone S, Abkevich V, Russell DL, et al. TBC1D1 is a candidate for a severe obesity gene and evidence for a gene/gene interaction in obesity predisposition. Hum Mol Genet 2006;15:2709-2720.
21. Meyre D, Farge M, Lecoeur C, et al. R125W coding variant in TBC1D1 confers risk for familial obesity and contributes to linkage on chromosome 4p14 in the French population. Hum Mol Genet 2008;17:1798-1802.
22. Chadt A, Immisch A, de Wendt C, et al. Deletion of both Rab-GTPaseactivating proteins TBC1D1 and TBC1D4 in mice eliminates insulin- And AICARstimulated glucose transport [published correction appears in Diabetes 2015;64: 1492]. Diabetes 2015;64:746-759.
23. Dokas J, Chadt A, Nolden T, et al. Conventional knockout of Tbc1d1 in mice impairs insulin- And AICAR-stimulated glucose uptake in skeletal muscle. Endocrinology 2013;154:3502-3514.
24. Szekeres F, Chadt A, Tom RZ, et al. The Rab-GTPase- Activating protein TBC1D1 regulates skeletal muscle glucose metabolism. Am J Physiol Endocrinol Metab 2012;303:E524-E533.
25. Chadt A, Leicht K, Deshmukh A, et al. Tbc1d1 mutation in lean mouse strain confers leanness and protects from diet-induced obesity. Nat Genet 2008;40: 1354-1359.
26. Hashiramoto M, James DE. Characterization of insulin-responsive GLUT4 storage vesicles isolated from 3T3-L1 adipocytes. Mol Cell Biol 2000;20:416-427.
27. James DE, Strube M, Mueckler M. Molecular cloning and characterization of an insulin-regulatable glucose transporter. Nature 1989;338:83-87.
28. Cleasby ME, Davey JR, Reinten TA, et al. Acute bidirectional manipulation of muscle glucose uptake by in vivo electrotransfer of constructs targeting glucose transporter genes. Diabetes 2005;54:2702-2711.
29. Li J, Cantley J, Burchfield JG, et al. DOC2 isoforms play dual roles in insulin secretion and insulin-stimulated glucose uptake. Diabetologia 2014;57:2173-2182.
30. James DE, Kraegen EW, Chisholm DJ. Muscle glucose metabolism in exercising rats: comparison with insulin stimulation. Am J Physiol 1985;248:E575- E580.
31. Hoehn KL, Turner N, Swarbrick MM, et al. Acute or chronic upregulation of mitochondrial fatty acid oxidation has no net effect on whole-body energy expenditure or adiposity. Cell Metab 2010;11:70-76.
32. Prabhu AV, Krycer JR, Brown AJ. Overexpression of a key regulator of lipid homeostasis, Scap, promotes respiration in prostate cancer cells. FEBS Lett 2013;587:983-988.
33. Arola L, Herrera E, Alemany M. A new method for deproteinization of small samples of blood plasma for amino acid determination. Anal Biochem 1977;82: 236-239.
34. Montgomery MK, Hallahan NL, Brown SH, et al. Mouse strain-dependent variation in obesity and glucose homeostasis in response to high-fat feeding. Diabetologia 2013;56:1129-1139.
35. Cartee GD, Funai K. Exercise and insulin: convergence or divergence at AS160 and TBC1D1? Exerc Sport Sci Rev 2009;37:188-195.
36. Dash S, Sano H, Rochford JJ, et al. A truncation mutation in TBC1D4 in a family with acanthosis nigricans and postprandial hyperinsulinemia. Proc Natl Acad Sci U S A 2009;106:9350-9355.
37. Dash S, Langenberg C, Fawcett KA, et al. Analysis of TBC1D4 in patients with severe insulin resistance. Diabetologia 2010;53:1239-1242.
38. Furler SM, Goldstein M, Cooney GJ, Kraegen EW. In vivo quantification of glucose uptake and conversion to glycogen in individual muscles of the rat following exercise. Metabolism 1998;47:409-414.
39. Pehmøller C, Treebak JT, Birk JB, et al. Genetic disruption of AMPK signaling abolishes both contraction- And insulin-stimulated TBC1D1 phosphorylation and 14-3-3 binding in mouse skeletal muscle. Am J Physiol Endocrinol Metab 2009;297:E665-E675.
40. Maarbjerg SJ, Jørgensen SB, Rose AJ, et al. Genetic impairment of AMPKalpha2 signaling does not reduce muscle glucose uptake during treadmill exercise in mice. Am J Physiol Endocrinol Metab 2009;297:E924-E934.
41. Merry TL, Steinberg GR, Lynch GS, McConell GK. Skeletal muscle glucose uptake during contraction is regulated by nitric oxide and ROS independently of AMPK. Am J Physiol Endocrinol Metab 2010;298:E577-E585.
42. O'Neill HM, Maarbjerg SJ, Crane JD, et al. AMP- Activated protein kinase (AMPK) beta1beta2 muscle null mice reveal an essential role for AMPK in maintaining mitochondrial content and glucose uptake during exercise. Proc Natl Acad Sci U S A 2011;108:16092-16097.
43. Lansey MN, Walker NN, Hargett SR, Stevens JR, Keller SR. Deletion of Rab GAP AS160 modifies glucose uptake and GLUT4 translocation in primary skeletal muscles and adipocytes and impairs glucose homeostasis. Am J Physiol Endocrinol Metab 2012;303:E1273-E1286.
44. Sargeant RJ, Pâquet MR. Effect of insulin on the rates of synthesis and degradation of GLUT1 and GLUT4 glucose transporters in 3T3-L1 adipocytes. Biochem J 1993;290:913-919.
45. Zisman A, Peroni OD, Abel ED, et al. Targeted disruption of the glucose transporter 4 selectively in muscle causes insulin resistance and glucose intolerance. Nat Med 2000;6:924-928.
46. James DE, Jenkins AB, Kraegen EW. Heterogeneity of insulin action in individual muscles in vivo: Euglycemic clamp studies in rats. Am J Physiol 1985; 248:E567-E574.